• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Here's the Single Most Important Detail in Pfizer's Q3 Update

cafead

Administrator
Staff member
  • cafead   Nov 04, 2021 at 10:22: AM
via
  • Pfizer delivered outstanding results in the third quarter with strong revenue and earnings growth.
  • The most important detail, though, in Pfizer's Q3 update was its forecast for 2022 COVID-19 vaccine sales.
  • Pfizer's Comirnaty guidance for 2022 is key because it sets a realistic expectation for investors.

article source
 

<